PeptideDB

KH7 330676-02-3

KH7 330676-02-3

CAS No.: 330676-02-3

KH7 (KH-7) is a novel and potent Inhibitor of Sac (soluble adenylyl cyclase) with IC50s of 3-10 μM against both recombi
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

KH7 (KH-7) is a novel and potent Inhibitor of Sac (soluble adenylyl cyclase) with IC50s of 3-10 μM against both recombinant purified human sACt protein and heterologously expressed sACt in cellular assays. It is also a cAMP inhibitor.



Physicochemical Properties


Molecular Formula C17H15BRN4O2S
Molecular Weight 419.297
Exact Mass 418.009
Elemental Analysis C, 48.70; H, 3.61; Br, 19.06; N, 13.36; O, 7.63; S, 7.65
CAS # 330676-02-3
PubChem CID 135496218
Appearance White to light yellow solid powder
Density 1.6±0.1 g/cm3
Index of Refraction 1.716
LogP 6.01
Hydrogen Bond Donor Count 3
Hydrogen Bond Acceptor Count 5
Rotatable Bond Count 5
Heavy Atom Count 25
Complexity 495
Defined Atom Stereocenter Count 0
SMILES

CC(C(N/N=C/C1=C(O)C=CC(Br)=C1)=O)SC1NC2=C(C=CC=C2)N=1

InChi Key WILMXUAKQKGGCC-DJKKODMXSA-N
InChi Code

InChI=1S/C17H15BrN4O2S/c1-10(25-17-20-13-4-2-3-5-14(13)21-17)16(24)22-19-9-11-8-12(18)6-7-15(11)23/h2-10,23H,1H3,(H,20,21)(H,22,24)/b19-9+
Chemical Name

2-(1H-benzimidazol-2-ylsulfanyl)-N-[(E)-(5-bromo-2-hydroxyphenyl)methylideneamino]propanamide
Synonyms

KH-7; KH7; KH 7
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets recombinant sACt ( IC50 = 3-10 μM )
ln Vitro KH7 (10 μM) inhibits this increase in cAMP caused by capture energy. In beer, KH7 significantly reduces basal cAMP accumulation, regardless of incubation medium, at higher concentrations (50 μM), 5 to 10 times higher than its IC50 and still selective against tmAC and sAC [1]. KH7 inhibits the synthesis of CaSF [2]. Myocytes exhibit a 20% negative inotropic effect (NIE) when KH7 is present, suggesting a role for sAC in the development of basal myocardial contractility [2].
References

[1]. The "soluble" adenylyl cyclase in sperm mediates multiple signaling events required for fertilization. Dev Cell. 2005 Aug;9(2):249-59.

[2]. Maresin Conjugates in Tissue Regeneration 1 improves alveolar fluid clearance by up-regulating alveolar ENaC, Na, K-ATPase in lipopolysaccharide-induced acute lung injury. 4.658J Cell Mol Med. 2020 Mar 11.


Solubility Data


Solubility (In Vitro) DMSO: ~250 mg/mL (~596.2 mM)
Solubility (In Vivo) Solubility in Formulation 1: 2.5 mg/mL (5.96 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.08 mg/mL (4.96 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.08 mg/mL (4.96 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.3849 mL 11.9246 mL 23.8493 mL
5 mM 0.4770 mL 2.3849 mL 4.7699 mL
10 mM 0.2385 mL 1.1925 mL 2.3849 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.